Big change is coming in 2023 – right down to the label

6 April 2023

2020_pills_tablets_bottles_biotech_manufacturing_production_big

Bob Tilling, VP of global sales at Kallik, provides an Expert View on certain key trends set to disrupt highly regulated industries through this year and beyond.

There have been huge changes in the way highly regulated markets operate in recent years – caused by new regulations, technologies and demands.

Manufacturers and businesses in sectors such as pharmaceuticals, cosmetics, and consumer packaged goods (CPG) need to be able to withstand the changes by adapting in 2023 – and packaging, labeling and artwork is critical.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK